[Federal Register Volume 83, Number 18 (Friday, January 26, 2018)]
[Notices]
[Pages 3711-3712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01381]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-1046; Docket No. CDC-2018-0008]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) Monitoring Activities. CDC is 
requesting a revision to this information collection project to include 
a redesigned survey and a new clinic-level data collection.

DATES: CDC must receive written comments on or before March 27, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0008 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note:  Submit all comments through the Federal 
eRulemaking portal (regulations.gov) or by U.S. mail to the address 
listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) Monitoring Activities--(OMB No. 0920-1046, exp. 01/31/2018)--
Reinstatement with Change--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    CDC is requesting a revision of the information collection with the 
OMB Control Number 0920-1046, formerly entitled ``Annual Survey of the 
National Breast and Cervical Cancer Early Detection Program Grantees' 
Program Implementation''. We are proposing a new title, ``National 
Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring 
Activities.'' In the previous OMB approval period, information 
collection consisted of an annual grantee survey. In the next OMB 
approval period, information collection will consist of a redesigned 
survey and a new clinic-level data collection. The number of 
respondents will increase from 67 to 70, and the total estimated 
annualized burden will increase from 45 to 683.
    Breast and cervical cancers are prevalent among women in the United 
States. In 2014, more than 236,000 women were diagnosed with breast 
cancer, and more than 12,000 women were diagnosed with cervical cancer. 
Evidence shows that deaths from both breast and cervical cancers can be 
avoided by increasing screening services among women. However, 
screening is typically underutilized among women who are under- or 
uninsured, have no regular source of healthcare, or who recently 
immigrated to the U.S. As a longstanding priority within chronic 
disease prevention, CDC focuses on increasing access to these cancer 
screenings, particularly among women who may be at increased risk.
    To improve access to cancer screening, Congress passed the Breast 
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 101-354), 
which directed CDC to create the National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP). The NBCCEDP currently provides

[[Page 3712]]

funding to 70 grantees under ``Cancer Prevention and Control Programs 
for State, Territorial, and Tribal Organizations (DP17-1701).'' NBCCEDP 
grantees include states or their bona fide agents; U.S. territories; 
and tribes or tribal organizations. The purpose of NBCCEDP is to 
increase breast and cervical cancer screening rates among women 
residing within defined geographical locations (as determined by the 
funded program) who are at or below 250% of the federal poverty level; 
aged 40-64 years for breast cancer services, and aged 21-64 years for 
cervical cancer services; and under- or uninsured.
    The NBCCEDP was significantly redesigned in 2017 to expand its 
focus on direct service provision to include implementation of 
evidence-based interventions (EBIs) intended to increase breast and 
cervical cancer screening at the population level. Based on the 
redesigned NBCCEDP, the information collection plan has also been 
redesigned. CDC is required to monitor and evaluate processes and 
outcomes related to the NBCCEDP.
    CDC proposes two forms of information collection. First, the 
NBCCEDP Grantee Survey was reconstructed to reflect the focus of the 
redesigned program under DP17-1701. The grantee survey will be 
submitted to CDC annually. Second, CDC proposes to collect clinic-level 
data to assess EBI implementation and the NBCCEDP's primary outcome of 
interest--breast and cervical screening rates within partner health 
system clinics. NBCCEDP grantees will collect and report baseline and 
annual clinic-level data for all partnering health system clinic 
sites--an estimated 6 clinics per grantee for breast cancer data and 6 
clinics per grantee for cervical cancer data. All information will be 
reported to CDC electronically.
    The proposed information collections will allow CDC to gauge 
progress in meeting NBCCEDP program goals and monitor implementation 
activities, evaluate outcomes, and identify grantee technical 
assistance needs. In addition, findings will inform program improvement 
and help identify successful activities that need to be maintained, 
replicated, or expanded.
    CDC seeks a three-year OMB approval. Participation is required for 
NBCCEDP grantees. There are no costs to respondents other than their 
time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondent            Form name       respondents   responses  per   response  (in    (in hours)
                                                                     respondent       hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees..............  NBCCEDP Grantee               70               1           45/60              53
                                 Survey.
NBCCEDP Grantees..............  NBCCEDP Clinic-               70               6           45/60             315
                                 level
                                 Information
                                 Collection
                                 Instrument--Bre
                                 ast.
NBCCEDP Grantees..............  NBCCEDP Clinic-               70               6           45/60             315
                                 level
                                 Information
                                 Collection
                                 Instrument--Cer
                                 vical.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             683
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-01381 Filed 1-25-18; 8:45 am]
 BILLING CODE 4163-18-P